Previous Close | 12.05 |
Open | 11.96 |
Bid | 12.71 x 800 |
Ask | 12.91 x 4000 |
Day's Range | 11.65 - 12.02 |
52 Week Range | 9.48 - 15.15 |
Volume | |
Avg. Volume | 2,014,980 |
Market Cap | 1.528B |
Beta (5Y Monthly) | 1.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for DVAX
Justin Burgess, the Chief Accounting Officer of Dynavax Technologies Corp (NASDAQ:DVAX), has sold 20,526 shares of the company on March 1, 2024, according to a recent SEC Filing.
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in. If you want to skip our overview of the global pharmaceutical and healthcare industry, which is one the most unique sectors in the world, then you can check out 5 Best Small Cap Pharma Stocks to […]
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript February 22, 2024 Dynavax Technologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and gentlemen and welcome to the Dynavax Technologies’ Fourth Quarter and Full Year 2023 […]